Analysis of the Frequency and Outcomes of Transformed Nodular Lymphocyte-Predominant Hodgkin Lymphoma in the United States: A Population-Based Study - Scorecard - MDSpire

Analysis of the Frequency and Outcomes of Transformed Nodular Lymphocyte-Predominant Hodgkin Lymphoma in the United States: A Population-Based Study

  • By

  • John L. Vaughn

  • Malak Munir

  • Ashley Cobb

  • Sravani Rimmalapudi

  • Narendranath Epperla

  • April 23, 2026

  • 0 min

Share

Clinical Scorecard: Analysis of the Frequency and Outcomes of Transformed Nodular Lymphocyte-Predominant Hodgkin Lymphoma in the United States: A Population-Based Study

At a Glance

CategoryDetail
ConditionTransformed Nodular Lymphocyte-Predominant Hodgkin Lymphoma (t-NLPHL)
Key MechanismsHistologic transformation to diffuse large B-cell lymphoma (DLBCL)
Target PopulationPatients aged 18–84 diagnosed with NLPHL between 2010 and 2022
Care SettingPopulation-based study using SEER-17 database

Key Highlights

  • Cumulative incidence of HT in NLPHL is 2.59% over 5.58 years.
  • Patients with t-NLPHL have significantly lower survival rates compared to non-transformed NLPHL.
  • Survival outcomes for t-NLPHL are comparable to de novo DLBCL.

Guideline-Based Recommendations

Diagnosis

  • Biopsy confirmation required for diagnosis of HT in NLPHL.

Management

  • Monitor for transformation in patients with NLPHL.

Monitoring & Follow-up

  • Regular follow-up to assess for signs of transformation.

Risks

  • Increased risk of poorer survival outcomes following transformation.

Patient & Prescribing Data

Patients with NLPHL, specifically those who may experience transformation.

Prior chemotherapy or radiation therapy did not significantly impact outcomes in t-NLPHL.

Clinical Best Practices

  • Consider demographic factors such as age, sex, and race when assessing risk of transformation.
  • Utilize flexible parametric survival models for outcome analysis.

References

Original Source(s)

Analysis of the Frequency and Outcomes of Transformed Nodular Lymphocyte-Predominant Hodgkin Lymphoma in the United States: A Population-Based Study

  • by John L. Vaughn, Malak Munir, Ashley Cobb, Sravani Rimmalapudi, Narendranath Epperla

  • April 23, 2026

Related Content

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?